Pay in 4 interest-free payments of $5.39 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
While these medications were originally used to treat type 2 diabetes, they are used off-label for treating individuals with obesity
As next-generation pharmacotherapies become available, clinicians must be prepared to reassess long-standing treatment targets and embrace a more ambitious, personalized approach to weight management.
In the SURPASS and SURMOUNT trials, nausea was reported in up to 32% of participants, diarrhea in 23%, vomiting in 12%, and constipation in 11%
These medications are widely viewed as a win for people struggling with weight loss
US$ 23.86
US$ 25.73
US$ 21.38
US$ 23.56
US$ 29.94
US$ 21.61
US$ 29.63
